Emmes

Emmes is a Contract Research Organization delivering complex clinical trials through therapeutic expertise, scientific rigor, and technology-enabled execution. For more than 45 years, Emmes has helped sponsors navigate the complexity of clinical development, supporting more than 2,150 clinical trials across 90+ countries and trial sites worldwide. We partner with biopharma, government, and non-profit organizations to design and deliver global studies across oncology, cell and gene therapy, vaccines and viral infectious diseases, and ophthalmology. Our therapeutic expertise is backed by rigorous clinical operations, biostatistics, data management, medical writing, and regulatory capabilities that generate high-quality, decision-ready evidence. The complexity of oncology, cell and gene therapy, vaccines and viral infectious diseases, and ophthalmology demands specialized execution. That's why purpose-built technology and AI are embedded throughout our delivery model, from clinical operations and data management to patient engagement, biostatistics, and trial oversight. These capabilities improve operational efficiency, enhance data quality, reduce complexity, and accelerate confident decision-making, helping sponsors bring new therapies to patients faster. Whether advancing first-in-human therapies, pivotal registration studies, or global public health programs, Emmes combines scientific excellence with modern clinical trial execution to deliver reliable evidence and meaningful outcomes. Partner with Emmes to advance your next clinical trial with the expertise, scale, and innovation to move complex research forward with confidence.